Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on modern management of frailty

LIVE: Thursday 17th October 2024, 18:00-19:30 (CEST)

Frailty has a significant impact on health and wellbeing, especially in older adults. Join our experts to understand the factors that contribute to the development of frailty and find out how to manage the condition and reduce the risk of disability, dependency, and mortality.
ADVANCED SEARCH
Log in
Top
BMC Anesthesiology
Published in:

Open Access 01-12-2023 | Esketamine | Research

Efficacy and safety of esketamine for sedation among patients undergoing gastrointestinal endoscopy: a systematic review and meta-analysis

Authors: Xianghong Lian, Yunzhu Lin, Ting Luo, Yang Jing, Hongbo Yuan, Yixin Guo

Published in: BMC Anesthesiology | Issue 1/2023

Login to get access

Abstract

Background

Patients who undergo gastrointestinal endoscopy often require propofol-based sedation combined with analgesics. At present, the efficacy and safety of esketamine as an adjunct to propofol for sedation during endoscopic procedures in patients remains controversial. Moreover, there is no universal agreement regarding the appropriate dose of esketamine supplementation. This study aimed to assess the efficacy and safety of esketamine as an adjunct to propofol for sedation during endoscopic procedures in patients.

Methods

Seven electronic databases and three clinical trial registry platforms were searched and the deadline was February 2023. Randomized controlled trials (RCTs) evaluating the efficacy of esketamine for sedation were included by two reviewers. Data from the eligible studies were combined to calculate the pooled risk ratio or standardized mean difference.

Results

Eighteen studies with 1962 esketamine participants were included in the analysis. As an adjunct to propofol, the administration of esketamine reduced the recovery time compared to normal saline (NS). However, there was no significant difference between the opioids group and ketamine group. For propofol dosage, the administration of esketamine required a lower propofol dosage compared to the NS group and opioids group].For complications, the esketamine group had fewer complications compared to the NS group and opioid group in patients, but there were no significant differences between the esketamine group and ketamine group. Notably, the coadministration of esketamine was associated with a higher risk of visual disturbance compared to the NS group. In addition, we used subgroup analysis to investigate whether 0.2–0.5 mg/kg esketamine was effective and tolerable for patients.

Conclusion

Esketamine as an adjunct to propofol, is an appropriate effective alternative for sedation in participants undergoing gastrointestinal endoscopy. However, considering the possibility of its psychotomimetic effects, esketamine should be used with caution.
Appendix
Available only for authorised users
Literature
1.
Cao H, Wang B, Zhang Z, Zhang H, Qu R. Distribution trends of gastric polyps: an endoscopy database analysis of 24 121 northern Chinese patients. J Gastroenterol Hepatol. 2012;27(7):1175–80.PubMedCrossRef
2.
Travis AC, Pievsky D, Saltzman JR. Endoscopy in the elderly. Am J Gastroenterol. 2012;107(10):1495–501.PubMedCrossRef
3.
ASGE Standards of Practice Committee, Early DS, Lightdale JR, Vargo JJ 2nd, Acosta RD, Chandrasekhara V, et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018;87(2):327–337.
4.
Friedrich-Rust M, Welte M, Welte C, Albert J, Meckbach Y, Herrmann E, et al. Capnographic monitoring of propofol-based sedation during colonoscopy. Endoscopy. 2014;46(3):236–44.PubMed
5.
Zhang W, Zhu Z, Zheng Y. Effect and safety of propofol for sedation during colonoscopy: A meta-analysis. J Clin Anesth. 2018;51:10–8.PubMedCrossRef
6.
Amornyotin S, Srikureja W, Chalayonnavin W, Kongphlay S. Dose requirement and complications of diluted and undiluted propofol for deep sedation in endoscopic retrograde cholangiopancreatography. Hepatobiliary Pancreat Dis Int. 2011;10(3):313–8.PubMedCrossRef
7.
Cohen LB, Delegge MH, Aisenberg J, Brill JV, Inadomi JM, KochmanML,et al. AGA Institute review of endoscopic sedation. Gastroenterology. 2007;133 (2):675–701.
8.
Carlsson U, Grattidge P. Sedation for upper gastrointestinal endoscopy: a comparative study of propofol and midazolam. Endoscopy. 1995;27(3):240–3.PubMedCrossRef
9.
Garewal D, Powell S, Milan SJ, Nordmeyer J, Waikar P. Sedative techniques for endoscopic retrograde cholangiopancreatography. Cochrane Database Syst Rev. 2012;13(6):CD007274.
10.
Park CH, Park SW, Hyun B, Lee J, Kae SH, Jang HJ, et al. Efficacy and safety of etomidate-based sedation compared with propofol-based sedation during ERCP in low-risk patients: a double-blind, randomized, noninferiority trial. Gastrointest Endosc. 2018;87(1):174–84.PubMedCrossRef
11.
Wang D, Chen C, Chen J, Xu Y, Wang L, Zhu Z, Deng D, Chen J, Long A, Tang D, Liu J. The use of propofol as a sedative agent in gastrointestinal endoscopy: a meta-analysis. PLoS ONE. 2013;8(1): e53311.PubMedPubMedCentralCrossRef
12.
Stokes DN, Hutton P. Rate-dependent induction phenomena with propofol: implications for the relative potency of intravenous anesthetics. Anesth Analg. 1991;72(5):578–83.PubMedCrossRef
13.
Aisenberg J, Cohen LB, Piorkowski JD Jr. Propofol use under the direction of trained gastroenterologists: an analysis of the medicolegal implications. Am J Gastroenterol. 2007;102(4):707–13.PubMedCrossRef
14.
Fabbri LP, Nucera M, Marsili M, Al Malyan M, Becchi C. Ketamine, propofol and low dose remifentanil versus propofol and remifentanil for ERCP outside the operating room: is ketamine not only a "rescue drug"? Med Sci Monit. 2012;18(9):CR575–580.
15.
Beers R, Camporesi E. Remifentanil update: clinical science and utility. CNS Drugs. 2004;18(15):1085–104.PubMedCrossRef
16.
Saad Z, Hibar D, Fedgchin M, Popova V, Furey ML, Singh JB, et al. Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials. Int J Neuropsychopharmacol. 2020;23(9):549–58.PubMedPubMedCentralCrossRef
17.
Krauss B, Green SM. Procedural sedation and analgesia in children. Lancet. 2006;367(9512):766–80.PubMedCrossRef
18.
Eberl S, Koers L, van Hooft J, de Jong E, Hermanides J, Hollmann MW, et al. The effectiveness of a low-dose esketamine versus an alfentanil adjunct to propofol sedation during endoscopic retrograde cholangiopancreatography: A randomised controlled multicentre trial. Eur J Anaesthesiol. 2020;37(5):394–401.PubMedCrossRef
19.
Wang J, Huang J, Yang S, Cui C, Ye L, Wang SY, et al. Pharmacokinetics and safety of esketamine in chinese patients undergoing painless gastroscopy in comparison with ketamine: a randomized. Open Label Clin Stud Drug Des Devel Ther. 2019;13:4135–44.CrossRef
20.
Xu Y, Zheng Y, Tang T, Chen L, Zhang Y, Zhang Z. The effectiveness of esketamine and propofol versus dezocine and propofol sedation during gastroscopy: a randomized controlled study. J Clin Pharm Ther. 2022;47(9):1402–8.PubMedCrossRef
21.
Higgins JPT, Green S. Cochrane Handbook for SystematicReviews of Interventions Version 5.1.0. 2011. London, UK: TheCochrane Collaboration. Available at www.​cochrane-handbook.​org. Accessed March 2011.
22.
23.
DerSimonian R, Laird N. Meta-analysis in clinical trials. ControlClin Trials. 1986;7(3):177–88.CrossRef
24.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta analysis. Stat Med. 2002;21(11):1539–58.PubMedCrossRef
25.
Li P, He W, Chen L, Guo L. Application of esketamine in painless colonoscopy and its effects on dreams and mood. J Clin Med Pract. 2022;26(6):86–9.
26.
Kang Y, Li C, Qu Y, Jia N, Li D. Study on the Clinical Anesthesia of low-dose Esketamine Combined with Propofol in Endoscopic Retrograde Cholangiopancreatography. Health Must Read. 2021;8:218.
27.
Shi Y. Effect of propofol combined with low-dose esketamine in painless gastroenteroscopy. Fertil Health. 2021;7:189–90.
28.
Li C, Shen Y, Xu Y, Zhang Z. Clinical observation of different doses of esketaminecombined with propofol in gastroscopy. Chin J New Drugs. 2022;31(8):773–7.
29.
Chen S, Zhu X, Zhao J, Zhai X, Liu H. Effect of Propofol Combined with Esketamine in Painless Gastroenteroscopy. Med Innov China. 2022;19(05):074–7.
30.
Shen K, Hu X, Wu Y, Weng L. Clinical study of low-dose esketamine combined with propofol in painless gastrointestinal endoscopy. China Acad J. 2022;57(3):341–4.
31.
Song Z, Li D. The anesthesia effect of esketamine in the diagnosis and treatment of painless gastrointestinal endoscopy in elderly patients. Acta Acad Med Weifang. 2021;43(06):475–7.
32.
Wan X, Yang Q, Fan D, Feng F, Ji M. Effect of subanesthetic dose of esketamine combined with propofol on painless gastroenterological endoscopy. J Clin Anesthesiol. 2022;38(02):144–8.
33.
Wang X, Yu M, Liu Z, Meng Q, Yu S, Li M. Application of s-ketamine combined with remimazolam in endoscopic retrograde cholangio-pancreatography. China Acad J. 2021;56(3):274–7.
34.
Yang H, Zhao Q, Chen HY, Liu W, Ding T, Yang B, et al. The median effective concentration of propofol with different doses of esketamine during gastrointestinal endoscopy in elderly patients: A randomized controlled trial. Br J Clin Pharmacol. 2022;88(3):1279–87.PubMedCrossRef
35.
Zheng XS, Shen Y, Yang YY, He P, Wang YT, Tao YY, et al. ED50 and ED95 of propofol combined with different doses of esketamine for children undergoing upper gastrointestinal endoscopy: A prospective dose-finding study using up-and-down sequential allocation method. J Clin Pharm Ther. 2022;47(7):1002–9.PubMedCrossRef
36.
Zeng L, Xiao Y, Li D, Zhang K. Study on the clinical anesthesia of esketamine combined with propofol in endoscopic retrograde cholangiopancreatography. Int J Front Med. 2022;4(3):7–11.
37.
Zhan Y, Liang S, Yang Z, Luo Q, Li S, Li J, et al. Efficacy and safety of subanesthetic doses of esketamine combined with propofol in painless gastrointestinal endoscopy: a prospective, double-blind, randomized controlled trial. BMC Gastroenterol. 2022;22(1):391.PubMedPubMedCentralCrossRef
38.
Wang J, Hu W, Zhao X, Ren W, Huang X, Zhang B. Sedative effect and safety of different doses of S-ketamine in combination with propofol during gastro-duodenoscopy in school-aged children: a prospective, randomized study. BMC Anesthesiol. 2022;22(1):346.PubMedPubMedCentralCrossRef
39.
Feng M, Shi G, Cui W, Zhang N, Xie Q, Zhang W. The median effective concentration of propofol in combination with different doses of esketamine during gastrointestinal endoscopy in adults. Front Pharmacol. 2022;13:1034236.PubMedPubMedCentralCrossRef
40.
Olofsen E, Boom M, Nieuwenhuijs D, Sarton E, Teppema L, Aarts L, et al. Modeling the non-steady state respiratory effects of remifentanil in awake and propofol-sedated healthy volunteers. Anesthesiology. 2010;112(6):1382–95.PubMedCrossRef
41.
Kitagawa N, Katoku M, Kasahara T, Tsuruta T, Oda M, Totoki T. Does atropine reduce the risk of propofol-induced cardiovascular depression? AnesthAnalg. 2006;103(6):1606–8.
42.
Hsu WH, Wang SS, Shih HY, Wu MC, Chen YY, Kuo FC, et al. Low effect-site concentration of propofol target-controlled infusion reduces the risk of hypotension during endoscopy in a Taiwanese population. J Dig Dis. 2013;14(3):147–52.PubMedCrossRef
43.
Coté GA, Hovis RM, Ansstas MA, Waldbaum L, Azar RR, Early DS, et al. Incidence of sedation-related complications with propofol use during advanced endoscopic procedures. Clin Gastroenterol Hepatol. 2010;8(2):137–42.PubMedCrossRef
44.
Varadarajulu S, Eloubeidi MA, Tamhane A, Wilcox CM. Prospective randomized trial evaluating ketamine for advanced endoscopic procedures in difficult to sedate patients. Aliment Pharmacol Ther. 2007;25(8):987–97.PubMedCrossRef
45.
Li X, Xiang P, Liang J, Deng Y, Du J. Global trends and hotspots in esketamine research: a bibliometric analysis of past and estimation of future trends. Drug Des Devel Ther. 2022;1(16):1131–42.CrossRef
46.
Chen HY, Meng XY, Gao H, Liu H, Qiu HB, Lu J, Song JC. Esketamine-based opioid-free anaesthesia alleviates postoperative nausea and vomiting in patients who underwent laparoscopic surgery: study protocol for a randomized, double-blinded, multicentre trial. Trials. 2023;24(1):13.PubMedPubMedCentralCrossRef
47.
Hung KC, Yew M, Lin YT, Chen JY, Wang LK, Chang YJ, et al. Impact of intravenous and topical lidocaine on clinical outcomes in patients receiving propofol for gastrointestinal endoscopic procedures: a meta-analysis of randomised controlled trials. Br J Anaesth. 2022;128(4):644–54.PubMedCrossRef
48.
Kara KA, Caner T. Comparison of pain in the early post-operative period using VAS score in patients after cardiac surgery who had minimally invasive incisions vs. full median sternotomy. Ann Ital Chir. 2019;90:3–9.
49.
Song N, Shan XS, Yang Y, Zheng Z, Shi WC, Yang XY, et al. Low-Dose Esketamine as an adjuvant to propofol sedation for same-visit bidirectional endoscopy: protocol for a multicenter randomized controlled trial. Int J Gen Med. 2022;15:4733–40.PubMedPubMedCentralCrossRef
50.
Sethi S, Wadhwa V, Thaker A, Chuttani R, Pleskow DK, Barnett SR, et al. Propofol versus traditional sedative agents for advanced endoscopic procedures: a meta-analysis. Dig Endosc. 2014;26(4):515–24.PubMedCrossRef
51.
Patrizi A, Picard N, Simon AJ, Gunner G, Centofante E, Andrews NA, et al. Chronic administration of the N-Methyl-D-aspartate receptor antagonist ketamine improves rett syndrome phenotype. Biol Psychiatry. 2016;79(9):755–64.PubMedCrossRef
52.
Nakao S, Nagata A, Miyamoto E, Masuzawa M, Murayama T, Shingu K. Inhibitory effect of propofol on ketamine-induced c-Fos expression in the rat posterior cingulate and retrosplenial cortices is mediated by GABAA receptor activation. Acta Anaesthesiol Scand. 2003;47(3):284–90.PubMedCrossRef
Metadata
Title
Efficacy and safety of esketamine for sedation among patients undergoing gastrointestinal endoscopy: a systematic review and meta-analysis
Authors
Xianghong Lian
Yunzhu Lin
Ting Luo
Yang Jing
Hongbo Yuan
Yixin Guo
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2023
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-023-02167-0

Other articles of this Issue 1/2023

BMC Anesthesiology 1/2023 Go to the issue

Research

Effect of surgical pleth index-guided remifentanil administration on perioperative outcomes in elderly patients: a prospective randomized controlled trial

Research

Dose-related adaptive reconstruction of DMN in isoflurane administration: a study in the rat

Research

Comparison of pulmonary function during interscalene block vs. supraclavicular block: a single-center, double-blind, randomized trial

Research

A retrospective study on the relationship between 5 modified frailty index (5-mFI) and postoperative complications of gynecological elderly patients undergoing abdominal surgery

Research

Effect of reverse Trendelenburg position and positive pressure ventilation on safe non-hypoxic apnea period in obese, a randomized-control trial

Research

Post-induction hypotension with remimazolam versus propofol in patients routinely administered angiotensin axis blockades: a randomized control trial